The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Dendritic cell-based immunotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Zeestraten, E. C. M., Speetjens, F. M., Welters, M. J. P., Saadatmand, S., Stynenbosch, L. F. M., Jongen, R., Kapiteijn, E., Gelderblom, H. A. J., Nijman, H. W., Valentijn, A. R. P. M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27819 · Cited by 64
Comparative evaluation of techniques for the manufacturing of dendritic cell‐based cancer vaccines
Dohnal, A. M., Graffi, S., Witt, V., Eichstill, C., Wagner, D., Ul‐Haq, S., Wimmer, D., & Felzmann, T. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00304.x · Cited by 63
Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
Aarntzen, E. H. J. G., Srinivas, M., Bonetto, F. J., Cruz, L. J., Verdijk, P., Schreibelt, G., van de Rakt, M. W. M. M., Lesterhuis, W. J., van Riel, M., Punt, C. J. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1879 · Cited by 62
Cytokine gene‐mediated immunotherapy: Current status and future perspectives
Jinushi, M., & Tahara, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01202.x · Cited by 61
Jongmans, W., Tiemessen, D. M., van Vlodrop, I. J. H., Mulders, P., & Oosterwijk, E. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000171290.78495.66 · Cited by 55
HIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44
Frleta, D., Ochoa, C. E., Kramer, H., Khan, S. A., Stacey, A., Borrow, P., Kessler, B. M., Haynes, B. F., & Bhardwaj, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64439 · Cited by 54
Self-citationConservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice
Yamazaki, C., Miyamoto, R., Hoshino, K., Fukuda, Y., Sasaki, I., Saito, M., Ishiguchi, H., Yano, T., Sugiyama, T., Hemmi, H., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.029 · Cited by 51
Vaccines, Adjuvants, and Dendritic Cell Activators—Current Status and Future Challenges
Obeid, J. M., Hu, Y., & Slingluff, C. L. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.05.006 · Cited by 50
Breckpot, K., Heirman, C., Greef, C. D., van der Bruggen, P., & Thielemans, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2232 · Cited by 48
Promises and challenges for the development ofListeria monocytogenes-based immunotherapies
Brockstedt, D. G., & Dubensky, T. W. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.1069 · Cited by 47
Woller, N., Knocke, S., Mundt, B., Gürlevik, E., Strüver, N., Kloos, A., Boozari, B., Schache, P., Manns, M. P., Malek, N. P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45585 · Cited by 47
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer
Nencioni, A., Müller, M., Grünebach, F., Garuti, A., Mingari, M. C., Patrone, F., Ballestrero, A., & Brossart, P. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700557 · Cited by 46
Sundarasetty, B. S., Chan, L., Darling, D., Giunti, G., Farzaneh, F., Schenck, F., Naundorf, S., Kuehlcke, K., Ruggiero, E., Schmidt, M., et al. (2015) · Gene Therapy · doi:10.1038/gt.2015.43 · Cited by 46
Bajor, D. L., Xu, X., Torigian, D. A., Mick, R., Garcia, L. R., Richman, L. P., Desmarais, C., Nathanson, K. L., Schuchter, L. M., Kalos, M. D., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0154 · Cited by 43
Rosario, M., Borthwick, N., Stewart-Jones, G. B. E., Mbewe‐Mvula, A., Bridgeman, A., Colloca, S., Montefiori, D. C., McMichael, A. J., Nicosia, A., Quakkelaar, E. D., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834ed9b2 · Cited by 38
Clonal analysis of human dendritic cell progenitor using a stromal cell culture
Lee, J., Breton, G., Aljoufi, A., et al. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.06.004 · Cited by 37
Lentiviral Vectors in Cancer Immunotherapy
Oldham, R. A. A., Berinstein, E. M., & Medin, J. A. (2015) · Immunotherapy · doi:10.2217/imt.14.108 · Cited by 37
KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity
Škoberne, M., Yewdall, A. W., Bahjat, K. S., Godefroy, E., Lauer, P., Lemmens, E. E., Liu, W., Luckett, W. S., Leong, M. L. L., Dubensky, T. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31350 · Cited by 36
Self-citationDifferentiation of Peripheral Blood Monocytes into Dendritic Cells
O’Neill, D. W., & Bhardwaj, N. (2005) · Current Protocols in Immunology · doi:10.1002/0471142735.im22f04s67 · Cited by 35
Self-citationFlörcken, A., Kopp, J., van Lessen, A., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24149 · Cited by 34
CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells
O’Brien, M. P., Manches, O., Wilen, C. B., Gopal, R., Huq, R., Wu, V., Sunseri, N., & Bhardwaj, N. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005553 · Cited by 30
Self-citationKumar, J., Kale, V. P., & Limaye, L. S. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0160-8 · Cited by 29
Dendritic cells derived from pluripotent stem cells: Potential of large scale production
Li, Y. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i1.1 · Cited by 25
Lentiviral vectors in cancer immunotherapy
Lin, S., Wang, B., & Wang, L. (2008) · 国际外科学杂志 · doi:10.3760/cma.j.issn.1673-4203.2008.03.011 · Cited by 23
Oncolytic viruses: focusing on the tumor microenvironment
de Vries, C. R., Kaufman, H. L., & Lattime, E. C. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.11 · Cited by 22
Yuan, J. D., Latouche, J., Reagan, J. L., Heller, G., Rivière, I., Sadelain, M., & Young, J. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.758 · Cited by 19
Kolanowski, S. T. H. M., Sritharan, L., Lissenberg‐Thunnissen, S. N., van Schijndel, G. M. W., van Ham, S. M., & ten Brinke, A. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2013.12.005 · Cited by 16
Mahdian, R., Kokhaei, P., Najar, H. M., Derkow, K., Choudhury, A., & Mellstedt, H. (2006) · Medical Oncology · doi:10.1385/mo:23:2:273 · Cited by 11
Cited by
Therapeutic Targeting of the Tumor Microenvironment
Bejarano, L., Jordāo, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,653
Lei, X., Lei, Y., Li, J.-K., Du, W.-X., Li, R.-G., Yang, J., Li, J., Li, F., & Tan, H.-B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.009 · Cited by 1,470
Meng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 592
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Immune Cell Membrane‐Coated Biomimetic Nanoparticles for Targeted Cancer Therapy
Oroojalian, F., Beygi, M., Baradaran, B., Mokhtarzadeh, A., & Shahbazi, M. (2021) · Small · doi:10.1002/smll.202006484 · Cited by 528
Metadata
- Authors
- Sabado, R. L., Balan, S., & Bhardwaj, N.
- Venue
- Cell Research
- Published
- 2016-12-27
- Volume
- 27
- Issue
- 1
- Pages
- 74-95
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W2561499686
- Cited by
- 927
- References
- 228
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.